The human Rgr oncogene is overexpressed in T-cell malignancies and induces transformation by acting as a GEF for Ras and Ral

Oncogene

Volumn 30, Issue 34, 2011, Pages 3661-3671

  Osei Sarfo, K ^a   Martello, L ^a,b   Ibrahim, S ^a   Pellicer, A ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

GEFs; Ral GTPases; Ras GTPases; Rgr; T cell lymphoma

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; PROTEIN TYROSINE PHOSPHATASE; RAL PROTEIN; RAS PROTEIN;

ARTICLE; CANCER GROWTH; CANCER INVASION; CELL CYCLE S PHASE; CONTROLLED STUDY; DISSOCIATION; ENZYME ACTIVATION; FIBROBLAST; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; ONCOGENE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTO ONCOGENE; T CELL LEUKEMIA;

CELL TRANSFORMATION, NEOPLASTIC; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, T-CELL; ONCOGENES; RAL GUANINE NUCLEOTIDE EXCHANGE FACTOR; RNA, MESSENGER;

ORYCTOLAGUS CUNICULUS;

EID: 80052055746     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.93     Document Type: Article

References (52)

1. Albright CF, Giddings BW, Liu J, Vito M, Weinberg RA. (1993). Characterization of a guanine nucleotide dissociation stimulator for a ras-related GTPase. EMBO J 12: 339-347. (Pubitemid 23042413)
2. Bhattacharya M, Anborgh PH, Babwah AV, Dale LB, Dobransky T, Benovic JL et al. (2002). Beta-arrestins regulate a Ral-GDS Ral effector pathway that mediates cytoskeletal reorganization. Nat Cell Biol 4: 547-555.
3. Bos JL. (1989). ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689. (Pubitemid 19213607)
4. Boykevisch S, Zhao C, Sondermann H, Philippidou P, Halegoua S, Kuriyan J et al. (2006). Regulation of ras signaling dynamics by Sos-mediated positive feedback. Curr Biol 16: 2173-2179. (Pubitemid 44767628)
5. Camonis JH, White MA. (2005). Ral GTPases: corrupting the exocyst in cancer cells. Trends Cell Biol 15: 327-332. (Pubitemid 40805329)
6. Cascone I, Selimoglu R, Ozdemir C, Del Nery E, Yeaman C, White M et al. (2008). Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs. EMBO J 27: 2375-2387.
7. Ceriani M, Scandiuzzi C, Amigoni L, Tisi R, Berruti G, Martegani E. (2007). Functional analysis of RalGPS2, a murine guanine nucleotide exchange factor for RalA GTPase. Exp Cell Res 313: 2293-2307. (Pubitemid 46891467)
8. Chardin P, Tavitian A. (1986). The ral gene: a new ras related gene isolated by the use of a synthetic probe. EMBO J 5: 2203-2208.
9. Chien Y, Kim S, Bumeister R, Loo YM, Kwon SW, Johnson CL et al. (2006). RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell 127: 157-170. (Pubitemid 44472624)
10. Chissoe SL, Bodenteich A, Wang YF, Wang YP, Burian D, Clifton SW et al. (1995). Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation. Genomics 27: 67-82.
11. Corominas M, Kamino H, Leon J, Pellicer A. (1989). Oncogene activation in human benign tumors of the skin (keratoacanthomas): is HRAS involved in differentiation as well as proliferation? Proc Natl Acad Sci USA 86: 6372-6376. (Pubitemid 19210654)
12. D'Adamo DR, Novick S, Kahn JM, Leonardi P, Pellicer A. (1997). Rsc: a novel oncogene with structural and functional homology with the gene family of exchange factors for Ral. Oncogene 14: 1295-1305. (Pubitemid 27151987)
13. Das J, Ho M, Zikherman J, Govern C, Yang M, Weiss A et al. (2009). Digital signaling and hysteresis characterize ras activation in lymphoid cells. Cell 136: 337-351.
14. Frankel P, Aronheim A, Kavanagh E, Balda MS, Matter K, Bunney TD et al. (2005). RalA interacts with ZONAB in a cell density-dependent manner and regulates its transcriptional activity. EMBO J 24: 54-62. (Pubitemid 40188463)
15. Garcia-Espana A, Salazar E, Sun TT, Wu XR, Pellicer A. (2005). Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior. Cancer Res 65: 1150-1157. (Pubitemid 40270138)
16. Gotoh T, Cai D, Tian X, Feig LA, Lerner A. (2000). p130Cas regulates the activity of AND-34, a novel Ral, Rap1, and R-Ras guanine nucleotide exchange factor. J Biol Chem 275: 30118-30123.
17. Hall BE, Yang SS, Boriack-Sjodin PA, Kuriyan J, Bar-Sagi D. (2001). Structure-based mutagenesis reveals distinct functions for Ras switch 1 and switch 2 in Sos-catalyzed guanine nucleotide exchange. J Biol Chem 276: 27629-27637.
18. Hernandez-Munoz I, Benet M, Calero M, Jimenez M, Diaz R, Pellicer A. (2003). Rgr oncogene: activation by elimination of translational controls and mislocalization. Cancer Res 63: 4188-4195. (Pubitemid 36917945)
19. Hernandez-Munoz I, Malumbres M, Leonardi P, Pellicer A. (2000). The Rgr oncogene (homologous to RalGDS) induces transformation and gene expression by activating Ras, Ral and Rho mediated pathways. Oncogene 19: 2745-2757. (Pubitemid 30339224)
20. Hofer F, Berdeaux R, Martin GS. (1998). Ras-independent activation of Ral by a Ca(2+)-dependent pathway. Curr Biol 8: 839-842. (Pubitemid 28324540)
21. Hofer F, Fields S, Schneider C, Martin GS. (1994). Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc Natl Acad Sci USA 91: 11089-11093. (Pubitemid 24349631)
22. Jullien-Flores V, Mahe Y, Mirey G, Leprince C, Meunier-Bisceuil B, Sorkin A et al. (2000). RLIP76, an effector of the GTPase Ral, interacts with the AP2 complex: involvement of the Ral pathway in receptor endocytosis. J Cell Sci 113(Part 16): 2837-2844.
23. Kurzrock R, Kantarjian HM, Druker BJ, Talpaz M. (2003). Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics. Ann Intern Med 138: 819-830. (Pubitemid 38124644)
24. Leonardi P, Kassin E, Hernandez-Munoz I, Diaz R, Inghirami G, Pellicer A. (2002). Human rgr: transforming activity and alteration in T-cell malignancies. Oncogene 21: 5108-5116.
25. Lim KH, Baines AT, Fiordalisi JJ, Shipitsin M, Feig LA, Cox AD et al. (2005). Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell 7: 533-545. (Pubitemid 40799247)
26. Lim KH, O'Hayer K, Adam SJ, Kendall SD, Campbell PM, Der CJ et al. (2006). Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. Curr Biol 16: 2385-2394. (Pubitemid 44894905)
27. Linnemann T, Kiel C, Herter P, Herrmann C. (2002). The activation of RalGDS can be achieved independently of its Ras binding domain. Implications of an activation mechanism in Ras effector specificity and signal distribution. J Biol Chem 277: 7831-7837. (Pubitemid 34968231)
28. Margarit SM, Sondermann H, Hall BE, Nagar B, Hoelz A, Pirruccello M et al. (2003). Structural evidence for feedback activation by Ras.GTP of the Ras-specific nucleotide exchange factor SOS. Cell 112: 685-695. (Pubitemid 36331780)
29. Mittar D, Sehajpal PK, Lander HM. (2004). Nitric oxide activates Rap1 and Ral in a Ras-independent manner. Biochem Biophys Res Commun 322: 203-209. (Pubitemid 39099256)
30. Muller AJ, Young JC, Pendergast AM, Pondel M, Landau NR, Littman DR et al. (1991). BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol Cell Biol 11: 1785-1792. (Pubitemid 21895544)
31. Ohta Y, Suzuki N, Nakamura S, Hartwig JH, Stossel TP. (1999). The small GTPase RalA targets filamin to induce filopodia. Proc Natl Acad Sci USA 96: 2122-2128.
32. Oxford G, Owens CR, Titus BJ, Foreman TL, Herlevsen MC, Smith SC et al. (2005). RalA and RalB: antagonistic relatives in cancer cell migration. Cancer Res 65: 7111-7120. (Pubitemid 41161240)
33. Oxford G, Theodorescu D. (2003). The role of Ras superfamily proteins in bladder cancer progression. J Urol 170: 1987-1993. (Pubitemid 37254994)
34. Paulsson K, Cazier JB, Macdougall F, Stevens J, Stasevich I, Vrcelj N et al. (2008). Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: unexpected similarities with pediatric disease. Proc Natl Acad Sci USA 105: 6708-6713. (Pubitemid 351754571)
35. Rodenhuis S. (1992). Ras and human tumors. Semin Cancer Biol 3: 241-247.
36. Roose JP, Mollenauer M, Ho M, Kurosaki T, Weiss A. (2007). Unusual interplay of two types of Ras activators, RasGRP and SOS, establishes sensitive and robust Ras activation in lymphocytes. Mol Cell Biol 27: 2732-2745. (Pubitemid 46581361)
37. Rosse C, Hatzoglou A, Parrini MC, White MA, Chavrier P, Camonis J. (2006). RalB mobilizes the exocyst to drive cell migration. Mol Cell Biol 26: 727-734. (Pubitemid 43089782)
38. Rowley JD. (1973). Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243: 290-293.
39. Sekido Y, Pass HI, Bader S, Mew DJ, Christman MF, Gazdar AF et al. (1995). Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res 55: 1227-1231.
40. Senga T, Iwamoto T, Kitamura T, Miyake Y, Hamaguchi M. (2001). JAK/STAT3-dependent activation of the RalGDS/Ral pathway in M1 mouse myeloid leukemia cells. J Biol Chem 276: 32678-32681.
41. Shao H, Andres DA. (2000). A novel RalGEF-like protein, RGL3, as a candidate effector for rit and Ras. J Biol Chem 275: 26914-26924.
42. Smith SC, Oxford G, Wu Z, Nitz MD, Conaway M, Frierson HF et al. (2006). The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer. Cancer Res 66: 1917-1922.
43. Sondermann H, Soisson SM, Boykevisch S, Yang SS, Bar-Sagi D, Kuriyan J. (2004). Structural analysis of autoinhibition in the Ras activator Son of sevenless. Cell 119: 393-405. (Pubitemid 39423841)
44. Sood R, Makalowska I, Carpten JD, Robbins CM, Stephan DA, Connors TD et al. (2000). The human RGL (RalGDS-like) gene: cloning, expression analysis and genomic organization. Biochim Biophys Acta 1491: 285-288. (Pubitemid 30173355)
45. Takai Y, Sasaki T, Matozaki T. (2001). Small GTP-binding proteins. Physiol Rev 81: 153-208. (Pubitemid 32098004)
46. Takaya A, Kamio T, Masuda M, Mochizuki N, Sawa H, Sato M et al. (2007). R-Ras regulates exocytosis by Rgl2/Rlf-mediated activation of RalA on endosomes. Mol Biol Cell 18: 1850-1860. (Pubitemid 46717565)
47. Tazmini G, Beaulieu N, Woo A, Zahedi B, Goulding RE, Kay RJ. (2009). Membrane localization of RasGRP1 is controlled by an EF-hand, and by the GEF domain. Biochim Biophys Acta 1793: 447-461.
48. Tchevkina E, Agapova L, Dyakova N, Martinjuk A, Komelkov A, Tatosyan A. (2005). The small G-protein RalA stimulates metastasis of transformed cells. Oncogene 24: 329-335. (Pubitemid 40188581)
49. Urano T, Emkey R, Feig LA. (1996). Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. EMBO J 15: 810-816. (Pubitemid 26064287)
50. Wigler M, Pellicer A, Silverstein S, Axel R. (1978). Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell 14: 725-731. (Pubitemid 9190247)
51. Wolthuis RM, Bauer B, vant't Veer LJ, de Vries-Smits AM, Cool RH, Spaargarer M et al. (1996). RalGDS-like factor (Rlf) is a novel Ras and Rap1A-associating protein. Oncogene 13: 353-362. (Pubitemid 26334867)
52. Zahir N, Lakins JN, Russell A, Ming W, Chatterjee C, Rozenberg GI et al. (2003). Autocrine laminin-5 ligates alpha6beta4 integrin and activates RAC and NFkappaB to mediate anchorage-independent survival of mammary tumors. J Cell Biol 163: 1397-1407. (Pubitemid 38032099)